8
Oct
2024

Nanjing King-Friend Pharma

Exhibitor at CPHI Milan 2024 stand 16B34, Finished Dosage Formulations
About Us

World's Leading Heparin/LMWH APIs supplier, with best supply.
Leading High-end Injectable products provider from China, with over 100 injectable product in pipeline, with US/China approvals.
US Top10 generic seller.
US FDA, EU EMA, Japan PMDA, Brazil ANVISA, Mexico COFEPRIS certified facilities.

  • CN
  • 2022
    On CPHI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Biopharmaceutical
Pharmaceutical Company (generic finished products)
Contact info
  • 16 Xuefu Road,High&New Tech Development Zone, 21006, Nanjing, J.S., China
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 16B34, Finished Dosage Formulations

Products Featured at CPHI Milan 2024

  • Heparin Sodium/ Enoxaparin Sodium

    Product Heparin Sodium/ Enoxaparin Sodium

    API and FDF both Approved in US, EU, China, Brazil US GMP, EU GMP, Japan GMP, China GMP, Brazil GMP, Mexico GMP available. World’s most stable supply, best quality, competitive price.